Celixir plc news
Celixir, a private company discovering and developing life-saving cell therapies, announces the appointment of Dr Mubasher Sheikh (Chairman), Professor Fiona Murray CBE, Professor Gary Pisano, Conor Kehoe and Professor Sir Martin Evans as Non-Executive Directors.
Celixir recently announced approval of a clinical trial application from the UK’s Medicines and Healthcare Products Regulatory Agency to initiate a potentially pivotal Phase IIb human clinical trial with its Heartcel&tr
Hockey for Heroes, a supporting charity of Help for Heroes who raise money to help our injured and fallen Heroes, today announces a multi-thousand pound sponsorship renewal with Celixir, a leading British Cell Therapy company.
Celixir continues as the charity’s main shirt sponsor for 2018-19, enabling Hockey for Heroes to expand its program to enable injured veterans to take part in adaptive sports and rehabilitation.
“Hockey for Heroes are honoured to be supported
Celixir (formerly Cell Therapy Limited) today announced the formation of the Innovative Cardiovascular Medicines Collaboration. The Collaboration includes world-leading expertise in cardiac research and clinical development, with the purpose of better understanding the basis for cardiac regeneration.
The Collaboration will be jointly led by Professor Kim Fox, Consultant Cardiologist and Professor of Cardiology at Imperial College and Professor Sir Martin Evans, No
Celixir, a leading British biotechnology company delivering breakthrough regenerative medicines, has today rebranded from Cell Therapy. The change reflects the company’s continued commitment to discovering, developing and delivering life-altering regenerative medicines, and transforming patient care.
“The name Celixir combines ‘Cell’ with the Latin root word elixir to convey our vision to develop curative regenerative medicines”, said Ajan Reginald, Chief
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines
- Promising cancer gene therapy programme using small interfering RNA (siRNA)
- Data from in vitro study published in PLOS journal
Stratford-upon-Avon, UK, 13 May 2019 – Celixir, a privately-owned company discovering and developing life-saving advanced the